Sofosbuvir: a review of its use in patients with chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Sofosbuvir: a review of its use in patients with chronic hepatitis C.

Sofosbuvir: a review of its use in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q38222679

about

Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy Hepatitis C virus: Virology, diagnosis and treatment Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.Daclatasvir: A Review in Chronic Hepatitis C.Electrophysiological Adverse Effects of Direct Acting Antivirals in Patients With Chronic Hepatitis C.Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.Simeprevir: a review of its use in patients with chronic hepatitis C virus infection.Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy.Pharmacokinetic drug evaluation of velpatasvir plus sofosbuvir for the treatment of hepatitis C virus infection.Sofosbuvir/Velpatasvir: A Review in Chronic Hepatitis C.Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C.Discovery of 2'-α-C-Methyl-2'-β-C-fluorouridine Phosphoramidate Prodrugs as Inhibitors of Hepatitis C Virus.Identification of Drug-Drug Interactions In Vitro: A Case Study Evaluating the Effects of Sofosbuvir and Amiodarone on hiPSC-Derived Cardiomyocytes.Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence.Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Tackling HCV-3 in Asia: Breakthroughs for Efficient and Cost-effective Treatment Strategies Sofosbuvir: A Potential Treatment for Ebola

P2860

Q26781743-7CF2050D-7169-4710-B296-BC50DDC4B9F3 Q28082000-A2CA03FC-3BE4-44EE-B161-3D0339B3A5E0 Q30244361-3BD103A8-FB22-4EB0-B14F-4CE7871D4478 Q30392100-85116D23-6132-43D6-9EB7-C111D05421C4 Q33168181-149384AB-83BC-4B24-866B-84546C8207B3 Q36166222-407A9DEE-68EA-4984-BAA3-3819D179DB8C Q38307580-8FB0D575-3EE6-4B3B-A573-68977F0B41D8 Q38703524-89C978D1-89AF-4E90-9C0D-EAE7D0C56CF6 Q38976791-49609FB3-2E11-4BC7-A589-58AF802CBDD2 Q38978513-F152C1EC-2FA4-48AA-9428-0E021E83F45D Q40104295-D1CC996B-3241-45DD-A5DA-1E8CF4E8EF9E Q40416944-7DF48D30-CF0E-4429-B57E-712DED1D0E05 Q40480795-4EF0CB52-F8CB-4DE8-8C34-F3A488D08FCE Q41668808-57B47FF7-D482-40B2-84D5-A08A77D6E1B0 Q57945693-2820F9A2-9414-4797-A8B5-51E633AB8E0A Q57946696-FFFE295A-0E01-4F33-8AA4-61ABC5728F34 Q58576148-E229CDD2-03EC-4EC4-99A1-E35C69D16568

P2860

Sofosbuvir: a review of its use in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q38222679

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Sofosbuvir: a review of its use in patients with chronic hepatitis C.

@en

type

label

Sofosbuvir: a review of its use in patients with chronic hepatitis C.

@en

prefLabel

Sofosbuvir: a review of its use in patients with chronic hepatitis C.

@en

P1433

Q38222679-1EC09BCA-81ED-4D48-9CE2-D0C888F177C5

P1476

Q38222679-4D646193-3526-4FEF-812C-F09AF6DEDB15

P2860

Q38222679-058FDF2A-6A79-454F-9BE5-633987385C74

Q38222679-087FACA1-4009-4449-9038-90BAE87DA8D4

Q38222679-12E33EE2-D42D-434D-9552-D7778F59B7C7

Q38222679-25D692E5-BFC6-4337-904C-AF69AB020F5F

Q38222679-2BA75938-6F11-4C7B-A059-C93A8BD0341E

Q38222679-39745210-950F-461C-BD1E-962B752F9640

Q38222679-442DDBC7-68FB-476C-B25B-7B7B2439C391

Q38222679-4A94A292-892E-4136-BC39-10A63EF4EA7F

Q38222679-4B7043E7-27D5-4316-AD47-7D90292F208A

Q38222679-57F7EAF6-5A0D-45D1-A6E3-1DB92F21E49E

P2888

Q38222679-5471971D-7E50-4FEC-92B4-06AFB9B2DE8B

P304

Q38222679-1F3F89A8-55C9-4F04-8D3F-1EA691B00A0C

P31

Q38222679-A1EBB11A-AA7F-41D9-9A3D-FC03B090D6F5

P356

Q38222679-DA38AE41-1EDC-41D4-9C6A-C241B71CEBBB

P433

Q38222679-1366BA16-DB8B-451E-AE75-70E767E8E7CE

P478

Q38222679-9D72E43C-752A-4D09-B746-A601B853E20F

P50

Q38222679-8EEF9E4B-DE0B-4205-A8E7-B70F3D0A45BE

P577

Q38222679-8A669B8F-C672-4500-9601-3D170DB420CA

P6179

Q38222679-D2A6553F-4C3B-4D8A-963C-654E7BC79466

P698

Q38222679-50F30D4C-3C0B-45E0-95B0-6DBC8C7C1F15

P921

Q38222679-55C771CA-6BC8-4BC0-A140-8101272E5AD9

P356

S40265-014-0247-Z

P1433

P1476

Sofosbuvir: a review of its use in patients with chronic hepatitis C.

@en

P2860

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

Diagnosis, management, and treatment of hepatitis C: an update

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

Sofosbuvir for previously untreated chronic hepatitis C infection

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin.

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.

P2888

s40265-014-0247-z

P304

1127-1146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-014-0247-Z

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Gillian M Keating

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017963029

http://www.w3.org/2001/XMLSchema#string

P698

24958336

http://www.w3.org/2001/XMLSchema#string

P921